Islet Sciences Receives Japanese Patent Covering New Medications for Diabetes

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies for people with diabetes, announced today the receipt of a Japanese Patent for allowed claims, Patent Application No. 2008-529208.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC